Data / Form D filings / bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc.: Form D filings
bioAffinity Technologies, Inc., a biotechnology company in San Anonio, TX, filed 5 Form D notices with the SEC between 2017 and 2024. The latest, on October 29, 2024, reports an offering of $4 million with nothing sold yet to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3300 NACOGDOCHES ROAD, SUITE 216, San Anonio, TX, 78217
- Phone
- (210) 698-5334
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1712762
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | New notice | $3,994,173 | $0 | $3,994,173 | 5 | Oct 21, 2024 | sec.gov |
| Aug 12, 2024 | New notice | $1,302,084 | $1,302,084 | 3 | Aug 2, 2024 | sec.gov | |
| Aug 12, 2024 | New notice | $450,000 | $450,000 | 3 | Aug 5, 2024 | sec.gov | |
| Mar 20, 2024 | New notice | $2,624,000 | $2,624,000 | 3 | Mar 6, 2024 | sec.gov | |
| Jul 26, 2017 | New notice | $4,047,993 | $4,047,993 | 39 | Jul 11, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stuart P. Diamond | Director | |
| Vivienne P. Rebel | Executive Officer | |
| Xavier P. Reveles | Executive Officer | |
| James Edwards | Executive Officer | |
| Robert S. Anderson | Director | |
| Maria Zannes | Executive Officer, Director | |
| Steven S. Girgenti | Executive Officer, Director | |
| Roby P. Joyce | Director | |
| Jamie S. Platt | Director | |
| Peter S. Knight | Director | |
| Gary S. Rubin | Director | |
| Timothy P. Zannes | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what bioAffinity Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.